Cheryl Lee, MDThe James Cancer Center
- Bladder Cancer
- Urethral Cancers
- Urologic Diseases
- Urogenital Cancers
Make an Appointment
As a urologist, I’ve focused my entire professional career on bladder cancer, which is very prevalent but often suffers from a lack of awareness and research to support our understanding of it. Research that advances new treatments and therapies for bladder cancer is very important to me.
I’ve served as principal investigator, co-principal investigator, site principal investigator or co-investigator for more than 50 clinical research trials. My latest study focused on strategies to improve outcomes and quality of life for patients who’ve suffered impairments following radical bladder cancer surgery.
At The Ohio State University I’m a tenured professor of urology and serve as chair of the department of urology for Ohio State’s Wexner Medical Center. Additionally, I serve in several national roles: as an oral board examiner of the American Board of Urology, as a member of the Education Council of the American Urological Association (AUA) and as a long-time postgraduate course director for the AUA.
I feel extremely fortunate and proud to be affiliated with the OSUCCC – James. In addition to our research, we’re committed to providing truly individualized care that focuses on total wellness. Our facilities are phenomenal and allow me to provide state-of-the-art care.
Education and Background
Albany Medical College
University of North Carolina Hospitals
Chapel Hill, NC
University of Michigan Hospitals
Ann Arbor, MI
Memorial Sloan-Kettering Cancer Center
- American Board of Urology
- Department of Urology
I see patients at
The James at Brain and Spine Hospital
300 West 10th Avenue, Columbus, Ohio 43210
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Lee has reported no financial relationships with medical device, research and/or drug companies.